Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial
- 1 September 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 384 (9948), 1118-1127
- https://doi.org/10.1016/s0140-6736(14)60418-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural MesotheliomaJournal of Thoracic Oncology, 2012
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyThe Lancet Oncology, 2011
- Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest GroupJournal of Thoracic Oncology, 2011
- A systematic review of lung-sparing extirpative surgery for pleural mesotheliomaJournal of the Royal Society of Medicine, 2011
- The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma☆European Journal of Cardio-Thoracic Surgery, 2008
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- BTS statement on malignant mesothelioma in the UK, 2007Thorax, 2007
- Improved survival with VATS pleurectomy-decortication in advanced malignant mesotheliomaEuropean Journal of Surgical Oncology, 2005
- Area under the curve: A metric for patient subjective responses in episodic diseasesQuality of Life Research, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993